Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Week in Review

Summaries of each week's events in China biotech are provided free to all readers.  A weekly email newsletter providing direct links to these articles is also available - click here for free email newsletter...

Week in Review: $1.4 Billion in China Life Science Deals and Financings
Week in Review: Jiangsu Hansoh to Raise Up to $3 Billion in Hong Kong IPO
Week in Review: Nearly $1 Billion in Cross-Border China Biopharma Deals
Week in Review: Three More China Biopharmas Planning Hong Kong IPOs
Week in Review: Shanghai ChemPartner, a China CRO/CMO, Completes Reverse Merger
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Other Events



November 7–9, 2018

ChinaBio members can get a 20% discount with the promotion code"chinabio18"